As the chair of the Lilly Chemistry Advisory Board for the Lilly Tuberculosis Drug Discovery Initiative (LTBDDI), I am currently engaged in a collaborative drug discovery and development effort towards this important disease with the Infectious Disease Research Institute (IDRI, Seattle) and the NIH/NIAID. I am interested in expanding my involvements in any helpful way.